Becker Capital Management’s Boston Scientific BSX Stock Holding History

Becker Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$230K	Buy	3,658 +134	+4%	+$10.7K	0.01%	284
2025 Q4	$336K	Buy	3,524 +12	+0.3%	+$1.18K	0.01%	257
2025 Q3	$343K	Buy	3,512 +591	+20%	+$61.2K	0.01%	249
2025 Q2	$314K	Hold	2,921	–	–	0.01%	243
2025 Q1	$295K	Buy	2,921 +237	+9%	+$23.9K	0.01%	241
2024 Q4	$240K	Hold	2,684	–	–	0.01%	252
2024 Q3	$225K	Buy	+2,684	New	+$212K	0.01%	262
2015 Q1	–	Sell	-80,327	Closed	-$1.06M	–	142
2014 Q4	$1.06M	Sell	80,327 -14,376	-15%	-$184K	0.04%	88
2014 Q3	$1.12M	Sell	94,703 -3,117	-3%	-$39.3K	0.05%	89
2014 Q2	$1.25M	Sell	97,820 -18,723	-16%	-$243K	0.05%	89
2014 Q1	$1.58M	Sell	116,543 -253,613	-69%	-$3.33M	0.06%	91
2013 Q4	$4.45M	Sell	370,156 -45,566	-11%	-$538K	0.18%	85
2013 Q3	$4.88M	Sell	415,722 -1,061,973	-72%	-$11.5M	0.22%	83
2013 Q2	$13.7M	Buy	+1,477,695	New	+$12.5M	0.69%	63

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Becker Capital Management's BSX Position: Q1 2026 in Review

Becker Capital Management increased its Boston Scientific (BSX) stake by 3.8% in Q1 2026, buying an estimated $10.7K and bringing the position to 3,658 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #284.

Becker Capital Management first reported a position in BSX in Q2 2013 and has held it in 14 quarters since. The position peaked at $13.7M in Q2 2013. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Becker Capital Management held 3,658 shares of Boston Scientific worth $230K as of Q1 2026.
Becker Capital Management bought 134 Boston Scientific shares in Q1 2026, an estimated $10.7K.
Boston Scientific made up 0.01% of Becker Capital Management's portfolio in Q1 2026, its #284 holding.
Becker Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 14 quarters since.
Becker Capital Management's Boston Scientific position peaked at $13.7M in Q2 2013.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.